August 25, 2008 - The Focused Ultrasound Surgery Foundation will host an international symposium dedicated to the ...
Vascular Solutions' extraction catheters are simple aspiration catheters that make use of a vacuum syringe to withdraw blood clots (thrombus) from various arteries, including those of the coronary and peripheral vasculature.
August 25, 2008 – MedQuist announced the launch of PhysAssist IQ Web, powered by IQMax Inc., a mobile platform that ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the ...
August 26, 2008 - Cook Medical today said 200 medical centers in the U.S. have adopted its EVOLUTION Mechanical Dilator Sheath technology, a new tool designed to remove faulty, ineffective leads in patients with cardiac pacemakers.
Atrium Medical Corp.’s ClearWay RX is a therapeutic perfusion catheter indicated for localized delivery of therapeutic agents to the coronary and peripheral vasculature.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
August 25, 2008 - Angioplasty catheter maker AngioScore Inc. said today it submitted a citizen petition with the FDA ...
The Twin-Pass and Twin-Pass .023-inch dual access catheters feature an over-the-wire lumen and a rapid exchange lumen in ...
August 26, 2008 - In a major landmark for advanced interventional technology to treat aortic disease, the Zenith Branch ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Medtronic Inc. will showcase its Export Aspiration Catheter at TCT 2008. Recent results from an independent study, called TAPAS, showed that thrombus aspiration with the Export Aspiration Catheter prior to stenting can improve blood flow and survival rates in patients suffering acute myocardial infarction (AMI) compared to treatment with percutaneous coronary intervention (PCI) alone.
August 26, 2008 - Anthera Pharmaceuticals Inc. yesterday announced the initiation of the FRANCIS (Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression) clinical trial to examine the impact of varespladib when administered to patients within 96 hours of an acute coronary syndrome (ACS) event.
August 26, 2008 - Corgenix Medical Corp. announced its collaboration with BG Medicine whereby Corgenix' AtherOx products ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
August 25, 2008 - Concerns over problems with MRIs often not being properly cleaned and leading to the spread of ...
Neovasc (formerly Angiometrx) is the developer of the Metricath System, an arterial and in-stent measurement device that ...
August 25, 2008 - A study conducted by the Cardiovascular Research Institute, Washington Hospital Center, Washington, D ...
August 25, 2008
